
Translational neuroscience PhD candidate specializing in traumatic brain injury (TBI), cerebrovascular dysfunction, and neurocardiac regulation. Expertise in designing and executing longitudinal preclinical studies that integrate in vivo functional imaging, cardiac phenotyping, and mechanistic neuroinflammatory analysis. Proven track record in evaluating therapeutic interventions, including exercise and pharmacologic modulation, through clinically relevant endpoints. Ready to leverage extensive background in a Translational Neuroscience Scientist role within the industry to drive advancements in CNS therapeutic development.
Member, American Association of Pharmaceutical Scientists (AAPS), 2026